In the hypoperfused pancreatic cancer model, MC‐T‐DOX might be activated by MT1‐MMP on tumor ECs to release cilengitide; this locally released cilengitide improved tumor blood perfusion, thereby resulting in an improved accumulation and a wider distribution of MC‐T‐DOX into tumors. The gene discussed is MMP14; the disease is pancreatic neoplasm.